Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries

Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease
Susanne EderGert Mayer

Abstract

The number of patients with type 2 diabetes mellitus and diabetes mellitus-associated chronic kidney disease varies considerably between countries. Next to differences in genetic as well as life style risk factors, varying practices in medical care delivery might cause this diversity. The PROVALID study recruited 4000 patients with type 2 diabetes mellitus at the primary level of healthcare in five European countries (Austria, Hungary, The Netherlands, Poland and Scotland). Baseline data were used to describe patient characteristics and compare the adherence to ADA (American Diabetes Association) and KDIGO (Kidney Disease: Improving Global Outcomes) guidelines with respect to metabolic and blood pressure control, use of renin-angiotensin system-blocking agents, statins and acetylsalicylic acid between the countries. About 34.8% of the population had evidence of diabetes mellitus-associated chronic kidney disease. The median HbA1c level of the cohort was 6.8% (ranging from 6.5 in Poland to 7.0% in Scotland). Mean blood pressure was 136/79 (±17/10) and significantly higher in subjects with elevated albuminuria. These individuals also were more often treated with renin-angiotensin system-blocking agents (74.1% vs 84.6%), whereas t...Continue Reading

References

Aug 11, 2005·JAMA : the Journal of the American Medical Association·Cynthia M BoydAlbert W Wu
Jun 4, 2013·Lancet·Vivekanand JhaChih-Wei Yang
Jun 9, 2014·Primary Care Diabetes·Andrea ModestiRoberto Pedrinelli
Apr 22, 2015·Journal of the American Medical Informatics Association : JAMIA·Jessica S AnckerUNKNOWN HITEC Investigators
Jun 26, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Raymond VanholderWim Van Biesen
Jul 26, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Alexander KainzRainer Oberbauer
Jul 26, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Katharina BrückUNKNOWN European CKD Burden Consortium
Oct 21, 2015·Journal of the American Geriatrics Society·Yong-Fang KuoMukaila A Raji
Dec 24, 2015·Diabetes Care·UNKNOWN American Diabetes Association
Dec 24, 2015·Diabetes Care·UNKNOWN American Diabetes Association
Dec 24, 2015·Diabetes Care·UNKNOWN American Diabetes Association
Dec 25, 2015·Journal of the American Society of Nephrology : JASN·Katharina BrückUNKNOWN European CKD Burden Consortium

❮ Previous
Next ❯

Citations

May 12, 2019·Wiener klinische Wochenschrift·Thomas E DornerChristian Lackinger
Apr 14, 2020·Revista clínica española·J EnaUNKNOWN Investigadores del Grupo de Trabajo de Diabetes, Obesidad y Nutrición de la Sociedad Española de Medicina Interna

❮ Previous
Next ❯

Software Mentioned

SPSS
EUROASPIRE
PROVALID
QOF

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Adrian CovicERA-EDTA ERBP Advisory Board
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia
Richard K D EphraimBen A Eghan
© 2022 Meta ULC. All rights reserved